Sun, Dec 28, 2014, 8:10 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Ligand Pharmaceuticals Incorporated Message Board

tycobb1923 3 posts  |  Last Activity: Sep 29, 2014 4:49 PM Member since: Feb 26, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • tycobb1923 tycobb1923 Sep 29, 2014 10:45 AM Flag

    I agree in general with comments here, but feel the tone is too negative....not by you T_C16. Let's look at what just happened....they have another two very nice well results, that now incorporates at least 5 different counties in a play of over 300,000 acres, obtained at a very low cost. Its need to refinance is an issue, but obviously they now have proven assets by which to negotiate. The declining oil price is reason for concern as well, but Goodrich has also stated they are receiving premium pricing for their product compared to Permian and Bakken producers. The benefit/risk ratio has changed favorably, in my mind, compared to where we were just 6 months ago.

  • Reply to

    link to roche slide presentation

    by simon417 Sep 29, 2014 10:12 AM
    tycobb1923 tycobb1923 Sep 29, 2014 11:06 AM Flag

    ??? link? Any news on the triplet of the kadcycla, herceptin, and perjeta? Anybody calling for the demise of kadcyla based on the Perjeta information needs to take a closer look at current research trials in place. Regardless, the Perjeta news is great for anybody with HER2+ breast cancer. Congrats!....

  • Reply to

    link to roche slide presentation

    by simon417 Sep 29, 2014 10:12 AM
    tycobb1923 tycobb1923 Sep 29, 2014 4:49 PM Flag

    My bad.....I meant the 3-arm trial.....Marianne where Kadcyla is being investigated +/- Pertuzumab and compared to Herceptin + taxane. Major mistake on my part. Thanks for the correction.

LGND
52.96+1.1700(+2.26%)Dec 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST
RLI Corp.
NYSEFri, Dec 26, 2014 4:08 PM EST